A Critical 81-Nucleotide Mutation Detected in the Novel Coronavirus! Can Mutations Weaken the Virus?

Around the world, research into COVID-19 and the virus that causes it, SARS-CoV-2, is continuing rapidly. Using techniques such as next-generation sequencing, scientists are examining the genetic material of the novel coronavirus isolated in different parts of the world with advanced genetic tests. This enables them to identify mutations (changes), which are an inherent part of viruses, by comparing them with previous results. Understanding how the virus evolves is, of course, very important for controlling the course of the outbreak.
How Will the Novel Coronavirus Outbreak End?
At present, there are 3 possible scenarios for ending this pandemic: either a new vaccine, people around the world developing immunity, or the virus undergoing a mutation! Until now, the possibility that a mutation would reduce the virus's ability to infect people had been considered the least likely scenario.
Let us look at a study published on 1 May in Journal of Virology. Virologist Dr. Efrem Lim and colleagues at Arizona State University identified a mutation in the novel coronavirus genome characterized by a deletion (loss, removal) of 81 nucleotides. A similar mutation had been detected in the later stages of the outbreak of the SARS-CoV virus, which emerged in southern China in 2002, and it had been shown to weaken SARS-CoV.
Details of the Study
Nasopharyngeal swab samples from 382 patients were tested using polymerase chain reaction (RT-PCR) to detect SARS-CoV-2 genetic material. Of these 382 samples, collected from 24 January 2020 to 25 March 2020, five tested positive for SARS-CoV-2. The positive swab samples were then analyzed directly using next-generation sequencing (NGS), thus avoiding cell culture and the mutations that might arise in association with it. Viral genomes obtained from around the world and shared in a dataset were then compared with the viral genomes in the study using phylogenetic methods.
Genomic characterization revealed a deletion of 81 bases of genetic material encoding 27 amino acids in one of the virus isolates (AZ-ASU2923). This deletion was observed in the ORF7a gene. ORF7a is an ortholog of the ORF7a/X4 gene in SARS-CoV (genes with the same ancestral origin). This gene encodes a protein that allows coronaviruses to suppress and modulate the immune system of their host, the person they infect, to their own advantage. As previously observed in SARS-CoV, if viruses carrying this deletion become the predominant strain, this could make the novel coronavirus less dangerous.
Dr. Lim states that the 16,000 SARS-CoV-2 genetic sequences isolated to date actually represent only 0.5% of all strains. He therefore emphasizes that much more research is needed to understand these mutations and those that may emerge in the future, and to develop effective treatment strategies.

Figure 1. The figure above shows the genomic and evolutionary characterization of SARS-CoV-2. A) The three new viral genomes identified in the study are marked with red stars. B) Amino acid sequences encoded by the ORF7 gene in various SARS-CoV2 isolates (the deletion is shown with dashed lines). C) RT-PCR amplicon counts using primers directed at the ORF-7a N-terminus (end) for molecular confirmation of the deletion. These confirm the deletion in AZ-ASU2923.
- ALL OUR CORONAVIRUS ARTICLES -
Sources
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.